As shown in the five studies presented below, the JETi™ thrombectomy device demonstrated positive clinical outcomes in a variety of thrombosis cases.
Pin, R. on behalf of the JETi Registry Investigators, Primary analysis of the novel JETi™ mechanical thrombectomy system for the treatment of arterial thrombosis. LINC, Leipzig, Germany 2024 May 28-31.
The JETi Registry (JETi Peripheral Thrombectomy Registry NCT04370691) is an all-comers, prospective, single-arm, multicentre, post-market study designed to collect real-world data on the JETi™ Hydrodynamic Thrombectomy System.
Razavi et al., JVIR. 2021.
Prospective study investigating single-session treatment of iliocaval and iliofemoral venous thrombosis while evaluating potential for treatment on an outpatient basis.
Dandu et al., VAM. 2022.
Retrospective review of 27 patients treated with JETi™ for acute and subacute lower limb ischaemia.
Khalsa et al., JVIR. 2020.
Retrospective review of 30 patients treated with JETiTM for acute lower extremity venous thrombosis.
Cournoyer-Rodrigue et al., JVIR. 2019.
Retrospective evaluation of 18 consecutive acute venous thrombosis patients at a new JETiTM user facility.
MAT-2409395 v1.0
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
MAT-2105201 v1.0
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
MAT-2105201 v1.0
